Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul-Dec;7(2):150-153.
doi: 10.5005/jp-journals-10018-1237. Epub 2017 Sep 29.

Adrenal Insufficiency in Cirrhosis Patients: Evaluation of 108 Case Series

Hali Rakici  1
Affiliations

Adrenal Insufficiency in Cirrhosis Patients: Evaluation of 108 Case Series

Hali Rakici. Euroasian J Hepatogastroenterol. 2017 Jul-Dec.

Abstract

Aim: Adrenal insufficiency (AI) in cirrhosis is an issue that has recently gained momentum. It can be seen in both stable and critically ill (sepsis, septic shock, and gastrointestinal system bleeding) cirrhotic patients. Its prevalence exists in a wide range since standardization of diagnostic methods is lacking. We aimed to scrutinize this issue in a 108 case series.

Materials and methods: We studied the presence of AI and its stage in patients with cirrhosis and its complications by using cross-sectional study. Standard-dose short synacthen test (SD-SST) was performed in 108 patients that had Child C decompensated cirrhosis without critical illness and it was aimed to determine the prevalence of AI based on basal cortisol, peak cortisol, and delta cortisol (basal total cortisol minus peak cortisol after stimulation) levels.

Results: The prevalence of AI in cirrhosis was found to be 25% based on basal cortisol level of <140 nmol/L, 22.2% based on delta cortisol level of <250 nmol/L, and 29.6% based on peak cortisol level of <500 nmol/L.

Conclusion: Prevalence of AI shows variation in decompensated cirrhosis without critical illness depending on different measures used. More definite results can be obtained when more standardized criteria are widely put into use.How to cite this article: Rakici H. Adrenal Insufficiency in Cirrhosis Patients: Evaluation of 108 Case Series. Euroasian J Hepato-Gastroenterol 2017;7(2):150-153.

Keywords: Cirrhosis; Prevalence.; Adrenal insufficiency.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

References

    1. Trifan A, Chiriac S, Stanciu C. Update on adrenal insufficiency in patients with liver cirrhosis. World J Gastroenterol. 2013 Jan;19(4):445–456. - PMC - PubMed
    1. Fede G, Spadaro L, Tomaselli T, Privitera G, Germani G, Tsochatzis E, Thomas M, Bouloux PM, Burroughs AK, Purrello F. Adrenocortical dysfunction in liver disease: a systematic review. Hepatology. 2012 Apr;55(4):1282–1291. - PubMed
    1. Marik PE, Gayowski T, Starzl TE. Hepatic Cortisol Research and Adrenal Pathophysiology Study Group. The hepatoad-renal syndrome: a common yet unrecognized clinical condition. Crit Care Med. 2005 Jun;33(6):1254–1259. - PMC - PubMed
    1. Tsai MH, Peng YS, Chen YC, Liu NJ, Ho YP, Fang JT, Lien JM, Yang C, Chen PC, Wu CS. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology. 2006 Apr;43(4):673–681. - PubMed
    1. Bornstein SR, Allolio B, Arlt W, Barthel A, Wauchope AD, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy D. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016 Feb;101(2):364–389. - PMC - PubMed

LinkOut - more resources